Results 251 to 260 of about 601,423 (296)
ABSTRACT Current therapies for Parkinson's disease (PD) fail to concurrently address α‐synuclein (α‐syn) aggregation and microglia‐mediated neuroinflammation. Herein, we engineer a near‐infrared‐II (NIR‐II) phototheranostic nanoplatform, CAG/FD1080@MM‐aTRPV4, for synergistic regulation of microglial function and real‐time monitoring of PD pathology. We
Hsuan Lo +9 more
wiley +1 more source
Renal Shear Wave Elastography for Differentiating Vasculitic and Non-Vasculitic Acute Kidney Injury. [PDF]
Yıldırım F +11 more
europepmc +1 more source
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong +8 more
wiley +1 more source
Afatinib-associated pseudo-acute kidney injury. [PDF]
Nguyen J, Das D, Shah CV.
europepmc +1 more source
Acute kidney injury caused by traditional Chinese medicinal scorpion: Case report. [PDF]
Ma R, Zheng B, Han J, Wang J, Cai M.
europepmc +1 more source
A kappa opioid receptor agonist, difelikefalin, improves acute kidney injury in experimental sepsis models. [PDF]
Sawanobori Y +9 more
europepmc +1 more source
DUSP26 protects against acute kidney injury by dephosphorylating p53 at serine 312. [PDF]
Fu Y +6 more
europepmc +1 more source

